These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34667076)

  • 1. Changes in the reach of a smoking cessation program in Ontario, Canada, during the COVID-19 pandemic: a cross-sectional study.
    Minian N; Veldhuizen S; Tanzini E; Duench S; deRuiter WK; Barker M; Zawertailo L; Melamed OC; Selby P
    CMAJ Open; 2021; 9(4):E957-E965. PubMed ID: 34667076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of COVID-19 on smoking cessation outcomes in a large primary care treatment programme: an observational study.
    Veldhuizen S; Selby P; Wong B; Zawertailo L
    BMJ Open; 2021 Aug; 11(8):e053075. PubMed ID: 34446503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Smoking Behavior Since the Declaration of the COVID-19 State of Emergency in Japan: A Cross-sectional Study From the Osaka Health App.
    Koyama S; Tabuchi T; Okawa S; Kadobayashi T; Shirai H; Nakatani T; Miyashiro I
    J Epidemiol; 2021 Jun; 31(6):378-386. PubMed ID: 33746148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health impact of a novel smoking cessation outreach program in Ontario, Canada.
    Selby P; Voci S; Zawertailo L; Baliunas D; Dragonetti R; Hussain S
    BMC Public Health; 2018 Sep; 18(1):1117. PubMed ID: 30217187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights From the SmokeFree.gov Initiative Regarding the Use of Smoking Cessation Digital Platforms During the COVID-19 Pandemic: Cross-sectional Trends Analysis Study.
    El-Toukhy S
    J Med Internet Res; 2021 Mar; 23(3):e24593. PubMed ID: 33646963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of COVID-19-Related Disruptions on Service Use in a Large Smoking Cessation Program.
    Veldhuizen S; Mahinpey N; Zawertailo L; Minian N; Melamed O; Selby P
    Nicotine Tob Res; 2022 Oct; 24(10):1567-1572. PubMed ID: 35420694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ban on menthol-flavoured tobacco products predicts cigarette cessation at 1 year: a population cohort study.
    Chaiton MO; Nicolau I; Schwartz R; Cohen JE; Soule E; Zhang B; Eissenberg T
    Tob Control; 2020 May; 29(3):341-347. PubMed ID: 31147474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Impact of the New York State Smokers' Quitline on Population-Level Smoking Rates in New York.
    Mann N; Nonnemaker J; Davis K; Chapman L; Thompson J; Juster HR
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31739413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent E-Cigarette Use During Tobacco Dependence Treatment in Primary Care Settings: Association With Smoking Cessation at Three and Six Months.
    Zawertailo L; Pavlov D; Ivanova A; Ng G; Baliunas D; Selby P
    Nicotine Tob Res; 2017 Feb; 19(2):183-189. PubMed ID: 27613911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disentangling the roles of point-of-sale ban, tobacco retailer density and proximity on cessation and relapse among a cohort of smokers: findings from ITC Canada Survey.
    Fleischer NL; Lozano P; Wu YH; Hardin JW; Meng G; Liese AD; Fong GT; Thrasher JF
    Tob Control; 2019 Jan; 28(1):81-87. PubMed ID: 29519935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Exposure to Court-Ordered Tobacco Industry Antismoking Advertisements With Intentions and Attempts to Quit Smoking Among US Adults.
    Chido-Amajuoyi OG; Agaku I; Mantey DS; Yu RK; Shete S
    JAMA Netw Open; 2020 Jul; 3(7):e209504. PubMed ID: 32633765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the impact of the COVID-19 pandemic on a smoking cessation service in Derbyshire: An interrupted time series analysis.
    Gleeson H; Earnshaw J; Craig C; Hodson C; Szatkowski L
    PLoS One; 2024; 19(6):e0303876. PubMed ID: 38843162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postpartum mental illness during the COVID-19 pandemic: a population-based, repeated cross-sectional study.
    Vigod SN; Brown HK; Huang A; Fung K; Barker LC; Hussain-Shamsy N; Wright E; Dennis CL; Grigoriadis S; Gozdyra P; Corsi D; Walker M; Moineddin R
    CMAJ; 2021 Jun; 193(23):E835-E843. PubMed ID: 34099467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds.
    McCuistian C; Kapiteni K; Le T; Safier J; Delucchi K; Guydish J
    J Subst Abuse Treat; 2022 Apr; 135():108640. PubMed ID: 34743925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Effectiveness of Pharmaceutical Smoking Cessation Aids: Time-Varying Effects.
    Chaiton M; Diemert LM; Bondy SJ; Cohen JE; Fung MD; Zhang BR; Ferrence RG
    Nicotine Tob Res; 2020 Apr; 22(4):506-511. PubMed ID: 30260455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Trends in Cessation Counseling, Prescription Medication Use, and Associated Costs Among US Adult Cigarette Smokers.
    Tibuakuu M; Okunrintemi V; Jirru E; Echouffo Tcheugui JB; Orimoloye OA; Mehta PK; DeFilippis AP; Blaha MJ; Michos ED
    JAMA Netw Open; 2019 May; 2(5):e194585. PubMed ID: 31125108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helping Smokers Quit: The Smoking Cessation Leadership Center Engages Behavioral Health by Challenging Old Myths and Traditions.
    Schroeder SA; Clark B; Cheng C; Saucedo CB
    J Psychoactive Drugs; 2018; 50(2):151-158. PubMed ID: 29279028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of exhaled carbon monoxide measured during an intervention program predict 1-year smoking cessation: a retrospective observational cohort study.
    Shie HG; Pan SW; Yu WK; Chen WC; Ho LI; Ko HK
    NPJ Prim Care Respir Med; 2017 Oct; 27(1):59. PubMed ID: 29038512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the United Kingdom's national smoking cessation strategy on quit attempts and use of cessation services: findings from the International Tobacco Control Four Country Survey.
    Gibson JE; Murray RL; Borland R; Cummings KM; Fong GT; Hammond D; McNeill A
    Nicotine Tob Res; 2010 Oct; 12 Suppl(Suppl 1):S64-71. PubMed ID: 20889483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
    Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
    Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.